Alimera Sciences (ALIM) Reports Second Quarter 2013 Financial Results
8/13/2013 6:13:33 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ATLANTA, Aug. 12, 2013 /PRNewswire/ -- Alimera Sciences, Inc. (ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the second quarter ended June 30, 2013.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by